| Structure |
Chemical Name |
CAS |
MF |
 |
Olaparib Adduct Impurity |
|
|
|
|
8-chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b] pyridine |
2514965-36-5 |
|
|
|
Febuxostat impurity EOX |
|
|
 |
2-Methyl-4-hydroxy-2H-1,2-benzisothiazine-3-carboxylic acid ethyl ester-1,1-diox |
35511-15-0 |
C11H11NO5S |
|
|
Olodaterol Impurity 26 |
|
|
![2H-3-Benzazepin-2-one, 3-[3-[[(2S)-3-chloro-2-(3,4-dimethoxyphenyl)propyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-](/CAS/20211123/GIF/2768438-46-4.gif) |
2H-3-Benzazepin-2-one, 3-[3-[[(2S)-3-chloro-2-(3,4-dimethoxyphenyl)propyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy- |
2768438-46-4 |
C27H37ClN2O5 |
|
|
Ethacridine Impurity 5 |
869002-00-6 |
|
|
|
Olodaterol Impurity 29 |
|
|
|
|
Elagolix Impurity 40 |
|
|
 |
8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-7-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
2365490-44-2 |
C13H8ClF2NO4 |
![[3-[[[2-(Diaminomethyleneamino)-4-thiazolyl]methyl]thio]propionyl]sulfamide](/CAS/GIF/106433-44-7.gif) |
[3-[[[2-(Diaminomethyleneamino)-4-thiazolyl]methyl]thio]propionyl]sulfamide |
106433-44-7 |
C8H14N6O3S3 |
 |
3-Formyl-25-desacetyl Rifamycin |
16783-97-4 |
C36H45NO12 |
![4-(3-Methylphenyl)-2H-pyrido[4,3-e]-1,2,4-thiadiazin-3(4H)-one 1,1-Dioxide](/CAS/GIF/72810-61-8.gif) |
4-(3-Methylphenyl)-2H-pyrido[4,3-e]-1,2,4-thiadiazin-3(4H)-one 1,1-Dioxide |
72810-61-8 |
C13H11N3O3S |
 |
8-Desacetyl-8-carboxy Daunorubicin Hydrochloride |
58199-96-5 |
C26H27NO11.ClH |
 |
D,L N,O-Didesmethylvenlafaxine |
135308-74-6 |
C15H23NO2 |
 |
Desmethyl Erlotinib Acetate |
183320-15-2 |
C23H23N3O5 |
 |
Erythromycin E_x000b_Discontinued |
41451-91-6 |
C37H65NO14 |
|
|
Avermectin A1a, 25-cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-23-hydroxy-5-(hydroxyimino)-, (23S)- (9CI) |
165108-08-7 |
C43H63NO12 |
 |
2-(3,4-dihydroxyphenyl)acetaldehyde |
5707-55-1 |
C8H8O3 |
![1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetamide, N-[(1S)-1-[3-[3-[bis(methylsulfonyl)amino]-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)-](/CAS/20211123/GIF/2189684-58-8.gif) |
1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetamide, N-[(1S)-1-[3-[3-[bis(methylsulfonyl)amino]-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl]-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bS,4aR)- |
2189684-58-8 |
C40H34ClF10N7O7S3 |
 |
NSC 77154 |
4121-39-5 |
C8H9N5 |
 |
N-Methyl-N,N-bis(2-pyridylethyl)amine |
5452-87-9 |
C15H19N3 |
 |
4-(CHLOROMETHYL)BENZYL ALCOHOL 99 |
16473-35-1 |
C8H9ClO |
 |
4,4′-DIPHENOQUINONE (DQ) |
494-72-4 |
C12H8O2 |
 |
S-(+)-O-DESMETHYL VENLAFAXINE |
142761-12-4 |
C16H25NO2 |
 |
ACETYLSIMVASTATIN |
145576-25-6 |
C27H40O6 |
![5-[2-(4'-METHYLBIPHENYL)]TETRAZOLE](/CAS/GIF/120568-11-8.gif) |
5-[2-(4'-METHYLBIPHENYL)]TETRAZOLE |
120568-11-8 |
C14H12N4 |
 |
L-2-Aminobutanamide |
7324-11-0 |
C4H10N2O |
 |
Dihydro-Simvastatin |
92083-03-9 |
C25H40O5 |
|
|
Ceftriaxone Sodium impurity 3 |
|
|
|
|
Sugammadex sodium Monoiodo Impurity |
|
|
![(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine](/CAS/20200401/GIF/CB85422885.gif) |
(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine |
|
C20H23NO3 |
 |
Avatrombopag Impurity 22 |
570403-14-4 |
C31H38Cl2N6O3S2 |
 |
176760-99-9 |
176760-99-9 |
C17H13FN2O4 |
|
|
AMIKACIN IMPURITY A |
|
|
 |
FUROSEMIDE IMPURITY A |
|
C12H11ClN2O5S |
|
|
GLICLAZIDE IMPURITY F |
|
|
|
|
ONDANSETRON IMPURITY D |
|
|
|
|
PERINDOPRIL IMPURITY A |
|
|
 |
(E)-Ceftiofur |
120882-20-4 |
C19H17N5O7S3 |
|
|
Cefmetazole Impurity E |
|
|
|
|
Aztreonam USP Impurity B |
|
|
 |
Azlocillin Opern-Ring Decarboxylation Impurity |
99795-14-9 |
C19H25N5O5S |
 |
Cefotiam Impurity 1 |
2243596-87-2 |
C18H23N9O4S3 |
|
|
Eribulin Impurity 3 |
|
|
|
|
sodium 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)-1-oxidopiperazin-1-yl)ethoxy)acetate |
|
|
 |
Brivaracetam Impurity 25 |
10547-88-3 |
C7H12O2 |
|
|
(S)-N-((R)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide |
|
|
|
|
Peramivir Impurity 19 |
|
|
 |
Diquafosol Impurity 13 |
211448-81-6 |
C18H28N4O29P6 |
 |
Montelukast Sodium EP Impurity G |
1428448-96-7 |
C35H37ClNNaO3S |
 |
Amifostine related impurities 2 |
17002-55-0 |
C8H21N3O |
 |
Oxacillin Impurity F |
5053-35-0 |
C19H19N3O4S2 |
 |
Peramivir Impurity 30 |
2758048-79-0 |
C20H36N2O6 |
 |
NILOTINIB IMPURITY 17 |
851137-91-2 |
C17H15N5O |
|
|
DexMedetoMidine IMpurity 16 |
|
|
 |
Canagliflozin Impurity 2 |
2952941-15-8 |
C18H14FIS |
|
|
Rivaroxaban Impurity 22 |
|
|
 |
Levofloxacin Impurity 5 |
2206360-62-3 |
C13H10FNO5 |
|
|
Ezetimibe Impurity 33 |
|
|
 |
Ezetimibe-28 |
1478663-95-4 |
C44H52F2N2O6Si |
|
|
Vonoprazan Impurity U4 |
|
|
 |
Emtricitabine Impurity 28 |
1238210-14-4 |
C8H11N3O4S |
|
|
Parecoxib SodiuM iMpurity 37 |
|
|
![(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound](/CAS/20200611/GIF/105834-21-7.gif) |
(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound |
105834-21-7 |
C20H22FNO3 |
|
|
Apixaban Impurity BMS-A |
|
|
 |
Afatinib Impurity 70 |
125781-04-6 |
C4H7ClO2 |
![Apixaban impurity 14/6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid](/CAS/20200611/GIF/1704504-93-7.gif) |
Apixaban impurity 14/6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid |
1704504-93-7 |
C20H18N4O4 |
 |
Cabozantinib Impurity 46 |
1247859-37-5 |
C11H10FNO3 |
 |
Ivabradine Impurity S33172 |
2247881-26-9 |
C26H34N2O5 |
|
|
Tenofovir Impurity 71 |
|
|
 |
2-(chloromethyl)-3-methylpyridin-4-ol |
1805648-51-4 |
C7H8ClNO |
 |
Mupirocin Calcium EP Impurity I |
|
C26H44CaO9 |
![Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod](/CAS/20210111/GIF/2243233-98-7.gif) |
Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod |
2243233-98-7 |
C46H55NO14 |
 |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester |
1326303-05-2 |
C16H26N2O4S2 |
![L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]-](/CAS/20200401/GIF/290298-02-1.gif) |
L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]- |
290298-02-1 |
C16H24N2O3 |
![5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy-](/CAS/20200401/GIF/2102609-59-4.gif) |
5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy- |
2102609-59-4 |
C14H18N2O2 |
 |
L-Milnacipran Carbamoyl-beta-D-Glucuronide |
1446438-98-7 |
C22H30N2O9 |
![1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester](/CAS/20200401/GIF/2097255-05-3.gif) |
1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester |
2097255-05-3 |
C40H34N8O10 |
|
|
Elagolix Sodium impurity5 |
|
|
|
|
Tadalafil Impurity 46 |
|
|
 |
(trans)-4-((2-amino-3,4-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
|
|
cefdinir |
|
|
|
|
ACICLOVIR, Impurity J |
|
|
 |
1H-Inden-1-amine, 2,3-dihydro-N-2-propen-1-yl- |
91639-43-9 |
C12H15N |
 |
Salbutamol impurity 42 |
18910-69-5 |
C14H23NO3 |
|
|
(E)-8-(3,4-dimethoxystyryl) |
|
|
|
|
tert-butyl (3R,5R)-7-((3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanamido)-3,5-dihydroxyheptanoate |
|
|
 |
(+)-Mediresinol Di-O-β-D-glucopyranoside |
88142-63-6 |
C33H44O17 |
|
|
(trans)-3-(4-((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl)butane-1,2,4-triol |
|
|
|
|
Cefdinir CP Impurity B |
|
|
 |
Voriconazole Impurity 15 |
321589-00-8 |
C22H19F4N7O |
|
|
Fluconazole Impurity 2 |
|
|
|
|
Imatinib EP Impurity D Chloride |
|
|
|
|
Favipiravir Impurity |
|
|
 |
Vildagliptin Dione Impurity |
1844894-70-7 |
C17H24N2O3 |
|
|
Adsorption of hydrogen sulfide Adsorption of impurities in water filter material |
|
|
 |
Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
1440961-11-4 |
C22H21FN2O6 |
![1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl-](/CAS/20210111/GIF/2170562-55-5.gif) |
1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl- |
2170562-55-5 |
C18H18FN3O3 |
 |
Apixaban Impurity 70 |
1998079-14-3 |
C44H40N8O9 |